1. Most mutations that cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16) destabilize the protein quality-control E3 ligase CHIP.
- Author
-
Kanack AJ, Newsom OJ, and Scaglione KM
- Subjects
- Amino Acid Substitution, Enzyme Stability, Fluorescence Polarization, Fluorescence Resonance Energy Transfer, HEK293 Cells, Hot Temperature adverse effects, Humans, Mutagenesis, Site-Directed, Mutation, Missense, Peptide Fragments chemistry, Peptide Fragments genetics, Peptide Fragments metabolism, Point Mutation, Protein Conformation, Recombinant Proteins chemistry, Recombinant Proteins metabolism, Solubility, Spinocerebellar Ataxias enzymology, Ubiquitin-Protein Ligases chemistry, Ubiquitin-Protein Ligases metabolism, Down-Regulation, Models, Molecular, Mutation, Spinocerebellar Ataxias genetics, Ubiquitin-Protein Ligases genetics, Ubiquitination
- Abstract
The accumulation of misfolded proteins promotes protein aggregation and neuronal death in many neurodegenerative diseases. To counteract misfolded protein accumulation, neurons have pathways that recognize and refold or degrade aggregation-prone proteins. One U-box-containing E3 ligase, C terminus of Hsc70-interacting protein (CHIP), plays a key role in this process, targeting misfolded proteins for proteasomal degradation. CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability. Here, we systematically analyzed CHIP mutations that cause SCAR16 and found that most SCAR16 mutations destabilize CHIP. This destabilization caused mutation-specific defects in CHIP activity, including increased formation of soluble oligomers, decreased interactions with chaperones, diminished substrate ubiquitination, and reduced steady-state levels in cells. Consistent with decreased CHIP stability promoting its dysfunction in SCAR16, most mutant proteins recovered activity when the assays were performed below the mutants' melting temperature. Together, our results have uncovered the molecular basis of genetic defects in CHIP function that cause SCAR16. Our insights suggest that compounds that improve the thermostability of genetic CHIP variants may be beneficial for treating patients with SCAR16., (© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2018
- Full Text
- View/download PDF